Crossmark

Pharmacological targeting of the protein synthesis mTOR/4E‐BP1 pathway in cancer‐associated fibroblasts abrogates pancreatic tumour chemoresistance

Published Online: 2015-04-01

Published Print: 2015-06-01

Authors

Duluc, Camille

Moatassim‐Billah, Siham

Chalabi‐Dchar, Mounira

Perraud, Aurélie

Samain, Rémi

Breibach, Florence

Gayral, Marion

Cordelier, Pierre

Delisle, Marie‐Bernadette

Bousquet‐Dubouch, Marie‐Pierre

Tomasini, Richard

Schmid, Herbert

Mathonnet, Muriel

Pyronnet, Stéphane

Martineau, Yvan

Bousquet, Corinne
Funding

Funding for this research was provided by:

LNCC

Labex TOUCAN

Canceropole Grand Sud‐Ouest (RMA04002BPA)

Fondation de France (2014 00047506)

French National Institute of Cancer (PLBIO13‐134)

French National Institute of Cancer (R13132BP)
License Information

Text and Data Mining valid from 2015-04-01

Version of Record valid from 2015-04-01
More Information

Article History

Received: 16 June 2014

Revised: 24 February 2015

Accepted: 26 February 2015

First Online: 1 April 2015

Conflict of interest

: The authors declare that they have no conflict of interest.

Document is current